Pricing

RespireRx Pharmaceuticals Inc (RSPID)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • Cortex Pharmaceuticals, Inc.
Stock Split History
DateRatio
2016-09-02 1:325
RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The company's lead ampakine, CX1739, has completed Phase II clinical studies for opioid-induced respiratory depression, as well as for central sleep apnea.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available